Literature DB >> 2323822

Production, characterization, and species specificity of monoclonal antibodies to Mycobacterium avium complex protein antigens.

D A Rouse1, S L Morris, A B Karpas, P G Probst, S D Chaparas.   

Abstract

The incidence of Mycobacterium avium-Mycobacterium intracellulare complex infections has increased in recent years primarily because a significant proportion of acquired immunodeficiency syndrome patients develop disseminated M. avium complex disease. In an effort to develop new tools to study these infections, we have produced eight monoclonal antibodies directed against M. avium. Western blot (immunoblot) specificity analysis and protease sensitivity assays indicate that four of these antibodies recognize M. avium-specific protein epitopes and two react with M. avium complex-specific peptide determinants. These monoclonal antibodies may be useful clinically in the diagnosis of M. avium complex disease and in the laboratory for isolation and characterization of native and recombinant M. avium complex antigens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323822      PMCID: PMC258645          DOI: 10.1128/iai.58.5.1445-1449.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG.

Authors:  M C Lu; M H Lien; R E Becker; H C Heine; A M Buggs; D Lipovsek; R Gupta; P W Robbins; C M Grosskinsky; S C Hubbard
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

3.  Production, characterization, and species specificity of five monoclonal antibodies to Mycobacterium tuberculosis.

Authors:  G V Kadival; S D Chaparas
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

Review 4.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Production and characterization of serovar-specific monoclonal antibodies to serovars 4, 8, and 9 of Mycobacterium intracellulare.

Authors:  K Nishimori; H Yugi; M Naiki; T Sugimura; Y Tanaka; I Nonomura; Y Yokomizo; S Kubo
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  The 65-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  T M Shinnick
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

7.  Genes for the major protein antigens of Mycobacterium tuberculosis: the etiologic agents of tuberculosis and leprosy share an immunodominant antigen.

Authors:  R N Husson; R A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 8.  Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

Authors:  L S Young; C B Inderlied; O G Berlin; M S Gottlieb
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

9.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

10.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

View more
  14 in total

1.  Detection of untreated mycobacteria by using polymerase chain reaction and specific DNA probes.

Authors:  J W Fries; R J Patel; W F Piessens; D F Wirth
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 2.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

3.  Molecular and immunological analyses of the Mycobacterium avium homolog of the immunodominant Mycobacterium leprae 35-kilodalton protein.

Authors:  J A Triccas; N Winter; P W Roche; A Gilpin; K E Kendrick; W J Britton
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Rapid detection of Mycobacterium avium in stool samples from AIDS patients by immunomagnetic PCR.

Authors:  Z Li; G H Bai; C F von Reyn; P Marino; M J Brennan; N Gine; S L Morris
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  Distinctive western blot antibody patterns induced by infection of mice with individual strains of the Mycobacterium avium complex.

Authors:  A Elsaghier; A Nolan; B Allen; J Ivanyi
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

6.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

8.  Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis.

Authors:  D A Rouse; S L Morris
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Production and analysis of specific monoclonal antibodies against the cell wall of Mycobacterium avium.

Authors:  S Wagner; U Klause; H Mauch
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

10.  Cloning and expression of the gene for the Avi-3 antigen of Mycobacterium avium and mapping of its epitopes.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; M Takahashi; Y Fukasawa; M Wada; C Abe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.